Patent details

EP2394643 Title: Sustained-release formulations of topiramate

Basic Information

Publication number:
EP2394643
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP111797767
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Sustained-release formulations of topiramate
French Title of Invention:
Formulations à libération prolongée de topiramate
German Title of Invention:
Topiramat-Formulierungen mit verzögerter Freisetzung
SPC Number:

Dates

Filing date:
16/11/2007
Grant date:
02/09/2015
EP Publication Date:
02/09/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/12/2011
EP B1 Publication Date:
02/09/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/11/2015
Expiration date:
16/11/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/11/2007
 
 

Name:
Supernus Pharmaceuticals Inc.
Address:
1550 East Gude Drive, Rockville, MD 20850, United States (US)

Inventor

1

Name:
Bhatt Padmanabh P.
Address:
United States (US)

2

Name:
Liang Likan
Address:
United States (US)

3

Name:
Wang Hua
Address:
United States (US)

4

Name:
Vieira Michael L.
Address:
United States (US)

Priority

Priority Number:
859502 P
Priority Date:
17/11/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/16;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages